LIVE WEBINAR
Share:

Acceptance Criteria for AI Validation: Determining What “Reliable” Actually Means in GxP Systems

  • Date
    10 August 2026
  • 12.00 PM Eastern Time (US/Canada)
    04.00 PM GMT

Course is now LIVE. Click below to join the session.

This course enables organizations to establish measurable acceptance criteria for AI-enabled GxP systems by defining reliability, oversight, and validation expectations that remain appropriate for risk-based regulatory environments. This course is designed for organizations evaluating, validating, governing, or overseeing AI-enabled systems supporting regulated quality, manufacturing, laboratory, and compliance activities.

/* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } /* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } .accordion-header::after { content: "◯"; font-size: 18px; transition: transform 0.25s ease; } .accordion-item.active .accordion-header::after { transform: rotate(90deg); }
REGISTRATION OPTIONS

Live session Plus
Complimentary 30 Days Streaming access

$290  |  One participant (viewer)

$390  |  Team (2 - 5 participants)

$490 |  Team (6 - 10 participants)

REGISTER FOR THE COURSE

US $290 per learner

30-Days Unlimited Streaming Access

/* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } /* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } .accordion-header::after { content: "◯"; font-size: 18px; transition: transform 0.25s ease; } .accordion-item.active .accordion-header::after { transform: rotate(90deg); }

REGISTER FOR THE COURSE

To Get 30-Day Access to ONLY this Course 

US $290 per learner
  • This course is Included in Subscription Pack
Subscription include access to entire Learning Library
/* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } /* Hide default + / - icon */ .accordion-toggle-icon { opacity: 0; } /* Add circle instead */ .accordion-header::after { content: "○"; font-size: 18px; margin-left: auto; transition: 0.2s ease; } /* When open → filled circle */ .accordion-item.active .accordion-header::after { content: "●"; } .accordion-header::after { content: "◯"; font-size: 18px; transition: transform 0.25s ease; } .accordion-item.active .accordion-header::after { transform: rotate(90deg); }
  • Faculty
    Carolyn Troiano
  • Duration
    90 Minutes
  • Course ID
    TF3243
  • Live Q&A +
    Post-live Continued Learning
  • Presentation Handout
    & Templates
  • Assessment
    & Certification Included

 

Why take this course?

Artificial intelligence is becoming integrated across regulated GxP activities, including quality systems, manufacturing support, laboratories, clinical operations, and regulatory processes. Unlike deterministic software, AI systems may produce variable outputs influenced by probabilistic models, performance drift, bias, hallucinations, and changing data. These characteristics require organizations to rethink how acceptance criteria are established and how reliability is evaluated before AI-enabled systems are used within regulated operations. 


This webinar examines practical approaches for defining meaningful, risk-based acceptance criteria for AI-enabled GxP systems while supporting FDA, EMA, MHRA, GAMP®, and data integrity expectations. Participants will evaluate measurable standards for reliability, consistency, explainability, traceability, auditability, human review, and exception handling. The session also addresses risk management, governance, lifecycle monitoring, and validation strategies that move beyond traditional deterministic approaches while supporting ongoing oversight as AI systems evolve after deployment.

Establish Meaningful AI Validation Standards 

Learn how to distinguish reliability, accuracy, and consistency when validating AI-enabled systems. Participants will evaluate measurable acceptance criteria, intended-use boundaries, confidence thresholds, traceability expectations, and escalation requirements that support risk-based validation decisions as regulatory expectations for AI oversight continue to mature. 

Strengthen Ongoing AI Governance 

Develop practical approaches for managing hallucinations, bias, performance drift, cybersecurity concerns, and data integrity risks throughout the AI lifecycle. The session explains how governance, periodic review, monitoring, and human review support continued confidence in AI-assisted GxP processes after deployment without relying solely on traditional validation methods. 

Key Areas Covered

  • Deterministic versus probabilistic AI validation 
  • Defining reliable AI performance 
  • Risk-based AI acceptance criteria 
  • Hallucination, bias, and drift management 
  • Human review responsibilities 
  • FDA CSA principles for AI 
  • AI governance lifecycle activities 
  • FDA, EMA, MHRA, GAMP® expectations 
  • Post-deployment monitoring and assurance 
  • AI validation inspection documentation 

Who Must Attend

  • Quality Departments
  • Computer System Validation Teams
  • IT and Digital Transformation Leaders
  • Regulatory Affairs Departments
  • Manufacturing Departments
  • Operations Departments
  • Laboratory Informatics and LIMS Administrators
  • Clinical Systems and Data Management Professionals
  • Data Integrity Specialists
  • Cybersecurity and AI Governance Teams
  • Compliance Officers and Auditors
  • Vendors and Consultants supporting GxP systems
  • Executive leadership evaluating AI adoption in regulated operations
Carolyn Troiano
COURSE DIRECTOR

Carolyn Troiano

Carolyn Troiano has more than 45 years of experience in computer system validation across pharmaceutical, biotechnology, medical device, tobacco, and other FDA-regulated industries. Her work in FDA compliance, Computer System Validation, 21 CFR Part 11, data integrity, and large-scale system implementation directly supports organizations validating AI-enabled GxP systems and defining reliable acceptance criteria. 

If you would like to request a Proforma invoice to sign up for this course. please click here

Commonly Asked Questions About This Subject

The following questions address practical regulatory, compliance, validation, quality, operational, and inspection-related considerations commonly associated with this subject.

How should acceptance criteria change when the same AI application is used for both low-risk and high-risk GxP activities? 

A single set of acceptance criteria should not automatically be applied across every intended use. Inspection discussions often begin when reviewers discover that one validated AI application supports activities with very different consequences, yet the organization evaluated all uses against identical performance expectations. 


An AI tool that assists with drafting internal meeting notes presents a different level of risk than one supporting batch review, deviation investigations, laboratory data interpretation, or regulatory submissions. Validation evidence should reflect those differences. 


Documentation becomes difficult to defend when intended use expands over time without reevaluating acceptance criteria. Teams frequently validate the application once, then gradually introduce additional use cases that were never included in the original assessment. 


Evidence that carries weight includes documented justification for each intended use, risk-specific performance expectations, clear operational boundaries, and records showing that new applications undergo additional evaluation before being adopted within regulated activities. 

What makes an AI validation package appear complete while still failing to demonstrate reliability? 

Documentation concern: validation packages often contain extensive testing records, protocols, and approvals while providing little evidence that the system will continue performing reliably under routine operational conditions. 


Inspection friction develops when testing relies almost entirely on expected or well-structured inputs. AI systems frequently behave differently when presented with ambiguous information, incomplete context, conflicting records, unusual terminology, or situations outside normal operating conditions. 


Reviewers generally look for evidence that the organization intentionally challenged the system rather than simply confirmed successful operation. Validation records become stronger when they demonstrate how unexpected responses were evaluated, what limitations were identified, and which operating boundaries were established. 


Reliability is generally supported by thoughtful challenge testing, documented limitations, predefined response criteria for unexpected behavior, and evidence that the system remains suitable for its intended use rather than by the volume of completed validation documentation. 

How should organizations respond when an AI system continues meeting validation criteria but its operational performance gradually changes? 

An operational failure point emerges when validation is viewed as a permanent conclusion rather than an ongoing assessment. AI applications may continue satisfying original acceptance thresholds while gradually producing outputs that differ in subtle but meaningful ways from historical performance. 


Inspection concerns often arise after users report increasing inconsistencies that were never formally evaluated because performance metrics remained within predefined limits. Small changes in output quality, consistency, terminology, or recommendation patterns may signal a gradual shift that deserves investigation. 


Documentation becomes less persuasive when operational observations remain informal or are handled outside the quality system. Those experiences often provide the earliest indication that additional evaluation is warranted. 


Well-controlled programs periodically compare current performance with historical expectations, investigate unexplained shifts, document observed changes, and reassess whether existing acceptance criteria continue to represent reliable performance within the intended GxP environment. 

What is the weakest justification for accepting AI-generated output during a validation review? 

A direct answer is that past success alone is a weak basis for acceptance. Statements such as "the system has always been accurate" or "we have never experienced a problem" provide little support during inspection because they describe historical experience rather than objective validation evidence. 


Reviewers generally expect organizations to explain why specific outputs were considered acceptable, what evaluation was performed, what uncertainties were identified, and how the conclusion was supported. Confidence based primarily on prior performance often becomes difficult to defend when unusual situations occur. 


Records become substantially stronger when acceptance decisions are tied to predefined criteria, documented evidence, representative testing, identified limitations, and traceable rationale. Those elements demonstrate that the organization reached its conclusions through a controlled evaluation process rather than through familiarity or historical trust in the application. 

Your TalkFDA Webinar Experience

When you reserve your seat, everything is organized for you — from access to certification from one place.

1. Confirmation

You receive a confirmation email and your course appears instantly in your TalkFDA dashboard.

2. Your Course Hub
Your TalkFDA course page becomes your central hub where you can join the session, access materials, and manage your learning.

3. Join the Live Training
At the scheduled time, click Join Session and you’ll be connected to the live Webex session with the instructor.

4. Watch Again Anytime
After the session, the playback becomes available on the same course page so you can revisit important sections.
5. Earn Your Certificate
Complete the course and your certificate is unlocked automatically in your learning history.

Everything related to your webinar: access, materials, playback, and certification — lives in one place.
Simple. Organized. Professional.
Go ahead and reserve your seat with confidence.

Built on 20+ years of global regulatory training experience across FDA, EMA, MHRA, and ICH frameworks.
Trusted by professionals across 80+ countries.

Testimonials

This is an upcoming session. Feedback below reflects experiences from similar programs delivered by our expert faculty.

“Session was easy to follow even for non-core team members. That helped.”
- Production Officer
“Good balance. Not too basic, not too deep. Worked well for mixed team.”
- Manager, Regulatory Affairs
“Team found it useful. Especially for aligning understanding across functions.”
- Director, Operations

Ready to Strengthen Your Team? Let’s Build Your Training Plan.

Whether you’re looking for a single onsite workshop or a multi-team training series, we’ll help you design a program that fits your goals, timelines, and operational reality.

Your team deserves the clarity.
Your organization deserves the confidence.

Upcoming Courses

Featured Courses